Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LOPINAVIR AND RITONAVIR TABLETS safely and effectively. See full prescribing information for LOPINAVIR AND RITONAVIR TABLETS. LOPINAVIR and RITONAVIR tablets, for oral use Initial U.S. Approval: 2000
Medication labelWhy this: Advisory · dailymed-prescription
Lopinavir and ritonavir tablets are indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients 14 days and older. Limitations of Use: • Genotypic or phenotypic testing and/or treatment history should guide the use of lopinavir and ritonavir tablets. The number of baseline lopinavir resistance-associated substitutions affects the virologic response to lopinavir and ritonavir tablets [see Microbiology (12.4)].
- generic_name
- lopinavir and ritonavir
- product_names
- Lopinavir and ritonavir
- ndc
- 31722-556, 31722-603, 31722-556-60, 31722-556-12, 31722-556-31, 31722-556-32, 31722-603-60, 31722-603-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en